Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Take a deep dive with the best Investors in MicroCapNEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Lixte生物技术控股公司（纳斯达克股票代码：LIXT）是一家专注于癌症药物开发的临床阶段药品公司，致力于开发和商业化新的癌症治疗方法。该公司除了进行演讲外，还将在整个一天内提供1对1的会议。
Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 2:00 pm ET
Location:
活动：Q3投资者峰会
日期：2024年8月20日
演讲时间：东部时间下午2点
位置：
The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
本次峰会主题是在当前市场上有催化剂和/或强劲表现的50个小市值公司。
与MicroCap最佳投资者深入探讨。
实时问答。
仅供合格投资者免费注册。请在此处注册。
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.
关于投资者峰会
投资者峰会是一家专注于连接小市值和微市值公司与合格投资者的独立会议。创立于2015年。
Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group
SOURCE: Lixte Biotechnology Holdings, Inc.
联系方式：
弗雷德·洛克威尔
fred@investorsummitgroup.com
投资者峰会集团
消息来源：Lixte生物技术控股公司。
